MACROGENICS INC - Common Stock (MGNX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MGNX on Nasdaq
Shares outstanding
62,912,484
Price per share
$1.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
45,995,618
Total reported value
$77,272,120
% of total 13F portfolios
0%
Share change
-2,289,555
Value change
-$2,545,324
Number of holders
101
Price from insider filings
$1.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MACROGENICS INC - Common Stock (MGNX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% -0.1% $11,269,840 +$35,800 6,296,000 +0.32% Armistice Capital, LLC 31 Mar 2025
WASATCH ADVISORS LP 3.1% -42% $3,276,482 -$2,584,186 1,950,287 -44% Wasatch Advisors LP 30 Sep 2025
BlackRock, Inc. 2.9% $2,194,571 1,813,695 BlackRock, Inc. 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 2.7% $3,086,408 1,724,250 Millennium Management LLC 31 Mar 2025
Frazier Life Sciences Public Fund, L.P. 2.5% $2,494,201 1,549,193 Frazier Life Sciences Public Fund, L.P. 30 Jun 2025

As of 30 Sep 2025, 101 institutional investors reported holding 45,995,618 shares of MACROGENICS INC - Common Stock (MGNX). This represents 73% of the company’s total 62,912,484 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MACROGENICS INC - Common Stock (MGNX) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bellevue Group AG 16% 9,919,992 0% 0.35% $16,665,587
ARMISTICE CAPITAL, LLC 9.5% 5,960,000 0% 0.31% $10,012,800
VANGUARD GROUP INC 6.7% 4,224,234 +0.26% 0% $7,096,714
Frazier Life Sciences Management, L.P. 5% 3,175,665 0% 0.16% $5,335,117
ACADIAN ASSET MANAGEMENT LLC 4% 2,517,547 +1% 0.01% $4,224,000
MILLENNIUM MANAGEMENT LLC 3.4% 2,116,870 +5% 0% $3,556,342
WASATCH ADVISORS LP 3.1% 1,950,287 -40% 0.02% $3,276,482
RENAISSANCE TECHNOLOGIES LLC 2.7% 1,701,223 +28% 0% $2,858,055
BlackRock, Inc. 2.4% 1,538,694 -15% 0% $2,585,006
MORGAN STANLEY 1.6% 989,233 +122% 0% $1,661,912
JANE STREET GROUP, LLC 1.3% 846,694 +12% 0% $1,422,446
JACOBS LEVY EQUITY MANAGEMENT, INC 1.3% 815,865 -19% 0.01% $1,370,653
JPMORGAN CHASE & CO 1.2% 755,245 +64% 0% $1,268,812
TWO SIGMA ADVISERS, LP 1.2% 748,600 -13% 0% $1,257,648
Connor, Clark & Lunn Investment Management Ltd. 1.1% 710,608 +4.2% 0% $1,193,821
GEODE CAPITAL MANAGEMENT, LLC 1% 657,521 -3.8% 0% $1,105,085
MARSHALL WACE, LLP 1% 629,535 +55% 0% $1,057,619
CITADEL ADVISORS LLC 0.78% 493,531 +188% 0% $829,132
TWO SIGMA INVESTMENTS, LP 0.69% 437,091 +7.3% 0% $734,313
MACQUARIE GROUP LTD 0.67% 420,000 0% 0% $706,000
Squarepoint Ops LLC 0.61% 385,633 +595% 0% $647,863
DIMENSIONAL FUND ADVISORS LP 0.55% 345,582 -32% 0% $580,863
PINNACLE ASSOCIATES LTD 0.54% 338,106 -3.7% 0.01% $568,018
Voleon Capital Management LP 0.49% 307,395 0.01% $516,424
Vestal Point Capital, LP 0.45% 280,000 0% 0.02% $470,400

Institutional Holders of MACROGENICS INC - Common Stock (MGNX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$49,740 $1.40 0
2025 Q3 45,995,618 $77,272,120 -$2,545,324 $1.68 101
2025 Q2 48,254,634 $58,417,269 -$6,816,378 $1.21 109
2025 Q1 53,787,262 $68,275,226 -$6,563,237 $1.27 124
2024 Q4 56,086,649 $182,277,562 +$1,567,680 $3.25 125
2024 Q3 54,902,225 $180,609,672 -$21,573,575 $3.29 119
2024 Q2 60,780,167 $258,313,062 -$142,568,369 $4.25 141
2024 Q1 64,754,082 $953,179,892 +$47,766,062 $14.72 160
2023 Q4 61,853,452 $595,031,063 +$42,076,156 $9.62 135
2023 Q3 58,037,496 $270,452,676 -$10,612,704 $4.66 125
2023 Q2 60,016,268 $321,083,284 +$4,896,794 $5.35 128
2023 Q1 58,447,529 $419,062,824 +$13,088,841 $7.17 134
2022 Q4 56,759,894 $380,843,944 +$1,005,535 $6.71 132
2022 Q3 57,575,517 $199,204,006 -$24,411,977 $3.46 125
2022 Q2 62,614,291 $184,903,988 -$36,679,744 $2.95 122
2022 Q1 60,299,794 $531,229,517 +$2,906,259 $8.81 137
2021 Q4 57,195,769 $918,067,066 -$24,934,268 $16.05 150
2021 Q3 57,874,256 $1,211,800,601 -$1,579,067 $20.94 148
2021 Q2 57,205,089 $1,536,547,929 +$8,981,504 $26.86 145
2021 Q1 56,061,432 $1,785,526,852 +$84,404,214 $31.85 172
2020 Q4 53,782,589 $1,229,394,378 -$4,957,016 $22.86 142
2020 Q3 53,058,543 $1,336,560,085 +$57,695,259 $25.19 135
2020 Q2 50,654,768 $1,414,302,624 +$299,006,012 $27.92 131
2020 Q1 44,072,517 $256,481,821 -$13,932,489 $5.82 115
2019 Q4 45,488,459 $494,902,348 -$13,404,901 $10.88 122
2019 Q3 46,464,006 $592,867,161 -$12,562,793 $12.76 120
2019 Q2 46,896,511 $795,717,581 +$190,321,437 $16.97 127
2019 Q1 43,999,290 $791,052,372 +$150,773,973 $17.98 152
2018 Q4 36,788,060 $467,188,625 -$29,674,211 $12.70 126
2018 Q3 36,789,217 $788,932,455 -$33,964,038 $21.44 126
2018 Q2 38,444,053 $793,879,768 +$10,342,160 $20.65 126
2018 Q1 37,720,122 $948,936,306 +$114,619,701 $25.16 130
2017 Q4 33,636,592 $638,496,847 +$15,104,735 $19.00 115
2017 Q3 31,580,541 $583,134,305 +$5,299,720 $18.48 111
2017 Q2 31,326,219 $548,559,268 +$40,918,864 $17.51 111
2017 Q1 28,885,755 $537,331,176 +$37,794,433 $18.60 110
2016 Q4 29,059,096 $593,934,489 -$14,285,927 $20.44 127
2016 Q3 28,232,393 $844,416,283 +$4,369,879 $29.91 128
2016 Q2 28,121,396 $758,990,766 +$13,826,968 $26.99 120
2016 Q1 27,896,098 $522,962,644 +$2,321,086 $18.75 125
2015 Q4 27,649,274 $856,321,717 +$11,376,068 $30.97 128
2015 Q3 27,323,666 $585,251,686 +$102,312,506 $21.42 124
2015 Q2 21,893,468 $831,287,412 +$79,012,592 $37.97 127
2015 Q1 19,955,304 $626,454,002 +$94,283,734 $31.37 112
2014 Q4 16,815,059 $589,710,584 +$46,599,841 $35.07 106
2014 Q3 15,402,521 $321,915,508 +$1,939,698 $20.90 84
2014 Q2 15,292,805 $332,310,989 -$45,758,383 $21.73 89
2014 Q1 14,275,251 $397,192,815 +$111,531,189 $27.83 74